Moolec Science (MLECW) Long-Term Investments (2023 - 2026)
Moolec Science (MLECW) posted Long-Term Investments of $16.0 million for Q1 2026, little changed sequentially from $16.0 million in Q4 2025.
Moolec Science (MLECW) Long-Term Investments (2023 - 2026) Analysis & Trends
Moolec Science has reported Long-Term Investments for 4 years, with the latest figure at $16.0 million in Q1 2026.
- Quarterly Long-Term Investments changed N/A year-over-year to $16.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.0 million (changed N/A YoY) and the FY2025 annual result came in at $1.3 million, down 90.09% from the prior year.
- Long-Term Investments was little changed at $16.0 million in Q1 2026 per MLECW's latest filing, from $16.0 million in the prior quarter.
- Over five years, Long-Term Investments peaked at $16.0 million in Q4 2025 and troughed at $622823.0 in Q2 2023.
- A 4-year average of $9.4 million and a median of $12.9 million in 2024 frame the typical range for Long-Term Investments.
- The sharpest annual moves came in 2024 and 2025: Long-Term Investments soared 1978.18% in 2024, then plunged 90.09% in 2025.
- Over 4 years, Long-Term Investments stood at $622823.0 in 2023, then jumped by 1978.18% to $12.9 million in 2024, then climbed by 23.62% to $16.0 million in 2025, then changed by 0.0% to $16.0 million in 2026.
- According to Business Quant data, Long-Term Investments over the past three periods registered $16.0 million, $16.0 million, and $1.3 million for Q1 2026, Q4 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 5.79 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 9.83 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 1.77 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 22.17 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 372.10 Mn |
| 10 | Moolec Science | 8,617.72 | -1.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.00 Mn |
| Dec 31, 2025 | 16.00 Mn |
| Jun 30, 2025 | 1.28 Mn |
| Jun 30, 2024 | 12.94 Mn |
| Jun 30, 2023 | 622,823.00 |